$759.62 Million in Sales Expected for Acadia Healthcare Company Inc (ACHC) This Quarter

Share on StockTwits

Equities analysts forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will post $759.62 million in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for Acadia Healthcare’s earnings, with the highest sales estimate coming in at $775.50 million and the lowest estimate coming in at $713.48 million. Acadia Healthcare reported sales of $742.24 million during the same quarter last year, which would suggest a positive year over year growth rate of 2.3%. The business is expected to issue its next quarterly earnings results on Tuesday, May 7th.

On average, analysts expect that Acadia Healthcare will report full year sales of $3.17 billion for the current fiscal year, with estimates ranging from $3.12 billion to $3.20 billion. For the next year, analysts anticipate that the business will report sales of $3.35 billion, with estimates ranging from $3.27 billion to $3.39 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Acadia Healthcare.

Several equities analysts have recently commented on the company. Robert W. Baird reduced their target price on Acadia Healthcare from $40.00 to $38.00 and set a “neutral” rating for the company in a research note on Monday, March 4th. BidaskClub cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday, December 15th. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $30.00 target price for the company in a research note on Monday, February 18th. Deutsche Bank assumed coverage on Acadia Healthcare in a research note on Thursday, January 3rd. They set a “hold” rating and a $27.00 target price for the company. Finally, TheStreet cut Acadia Healthcare from a “c” rating to a “d” rating in a research note on Friday, March 1st. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $37.20.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. lifted its stake in Acadia Healthcare by 0.8% during the third quarter. BlackRock Inc. now owns 10,414,515 shares of the company’s stock worth $366,592,000 after purchasing an additional 77,802 shares during the last quarter. Vanguard Group Inc. increased its position in Acadia Healthcare by 2.5% in the third quarter. Vanguard Group Inc. now owns 7,399,082 shares of the company’s stock worth $260,447,000 after buying an additional 183,698 shares during the period. Vanguard Group Inc increased its position in Acadia Healthcare by 2.5% in the third quarter. Vanguard Group Inc now owns 7,399,082 shares of the company’s stock worth $260,447,000 after buying an additional 183,698 shares during the period. JPMorgan Chase & Co. increased its position in Acadia Healthcare by 3.5% in the third quarter. JPMorgan Chase & Co. now owns 6,033,366 shares of the company’s stock worth $212,375,000 after buying an additional 204,401 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Acadia Healthcare by 3.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 5,591,881 shares of the company’s stock worth $143,767,000 after buying an additional 176,791 shares during the period.

Shares of Acadia Healthcare stock traded up $0.49 on Tuesday, hitting $30.95. 58,710 shares of the company’s stock traded hands, compared to its average volume of 1,308,045. The stock has a market cap of $2.66 billion, a P/E ratio of 13.81, a price-to-earnings-growth ratio of 1.69 and a beta of 0.65. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 1.35. Acadia Healthcare has a 52-week low of $24.27 and a 52-week high of $45.35.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Short Selling Stocks and Day Traders

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Desjardins Comments on TFI International Inc.’s FY2019 Earnings
Desjardins Comments on TFI International Inc.’s FY2019 Earnings
BP plc  Stake Lessened by Sterling Investment Management Inc.
BP plc Stake Lessened by Sterling Investment Management Inc.
Valero Energy Co.  Shares Sold by Canandaigua National Bank & Trust Co.
Valero Energy Co. Shares Sold by Canandaigua National Bank & Trust Co.
Wright Investors Service Inc. Has $872,000 Position in BlackRock, Inc.
Wright Investors Service Inc. Has $872,000 Position in BlackRock, Inc.
Peoples Utah Bancorp  Director Sells $38,431.25 in Stock
Peoples Utah Bancorp Director Sells $38,431.25 in Stock
EnLink Midstream LLC Expected to Earn FY2021 Earnings of $0.41 Per Share
EnLink Midstream LLC Expected to Earn FY2021 Earnings of $0.41 Per Share


© 2006-2019 Ticker Report